Chemical Structure (Tybost 01)
Tybost Tablet, Film Coated
Product Images NDC 61958-1401
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tybost (NDC 61958-1401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (30 Tablet Bottle Label)
This is a report on the pharmacokinetics of two antiretroviral drugs - Darunavir and Cobicistat. The report provides information about the concentration of the drugs in the second and third trimester of pregnancy. The GMR (geometric mean ratio) and CI (confidence interval) are also mentioned. However, there is not enough context to deduce the purpose of the report or the significance of the data presented.*
Tybost 03
Tybost tablets contain 150 mg of cobicistat and should be stored at room temperature. They are dispensed in the original container and should be kept tightly closed. Dosage and administration instructions can be found in the package insert. Tybost is manufactured by Gilead Sciences, Inc., made in Canada, and is not to be taken with certain other medicines. The container has an ALERT box, which should not be covered by a pharmacy label.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
